vs

M-tron Industries, Inc.(MPTI)与ROCKWELL MEDICAL, INC.(RMTI)财务数据对比。点击上方公司名可切换其他公司

ROCKWELL MEDICAL, INC.的季度营收约是M-tron Industries, Inc.的1.3倍($18.3M vs $14.2M),M-tron Industries, Inc.净利率更高(24.1% vs -3.0%,领先27.1%),M-tron Industries, Inc.同比增速更快(11.2% vs -25.6%),M-tron Industries, Inc.自由现金流更多($2.3M vs $2.2M),过去两年M-tron Industries, Inc.的营收复合增速更高(12.8% vs -10.1%)

M-tron Industries, Inc.是一家研发生产高性能频率控制与计时解决方案的企业,产品涵盖晶体振荡器、滤波器、集成计时组件等,主要服务航空航天、国防、电信、工业自动化、医疗设备领域,客户覆盖北美、欧洲及亚洲的商业和政府机构。

罗克韦尔医疗成立于1996年,总部位于美国密歇根州威克瑟姆,是一家上市制药企业,核心业务聚焦于终末期肾病与慢性肾病相关治疗方案的研发与商业化推广。

MPTI vs RMTI — 直观对比

营收规模更大
RMTI
RMTI
是对方的1.3倍
RMTI
$18.3M
$14.2M
MPTI
营收增速更快
MPTI
MPTI
高出36.8%
MPTI
11.2%
-25.6%
RMTI
净利率更高
MPTI
MPTI
高出27.1%
MPTI
24.1%
-3.0%
RMTI
自由现金流更多
MPTI
MPTI
多$129.0K
MPTI
$2.3M
$2.2M
RMTI
两年增速更快
MPTI
MPTI
近两年复合增速
MPTI
12.8%
-10.1%
RMTI

损益表 — Q4 FY2025 vs Q4 FY2025

指标
MPTI
MPTI
RMTI
RMTI
营收
$14.2M
$18.3M
净利润
$3.4M
$-554.0K
毛利率
21.1%
营业利润率
27.3%
-2.2%
净利率
24.1%
-3.0%
营收同比
11.2%
-25.6%
净利润同比
60.1%
26.7%
每股收益(稀释后)
$0.90
$-0.01

绿色 = 该指标领先。财年不对齐时期间可能不同

8季度营收与利润趋势

并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配

营收
MPTI
MPTI
RMTI
RMTI
Q4 25
$14.2M
$18.3M
Q3 25
$14.2M
$15.9M
Q2 25
$13.3M
$16.1M
Q1 25
$12.7M
$18.9M
Q4 24
$12.8M
$24.7M
Q3 24
$13.2M
$28.3M
Q2 24
$11.8M
$25.8M
Q1 24
$11.2M
$22.7M
净利润
MPTI
MPTI
RMTI
RMTI
Q4 25
$3.4M
$-554.0K
Q3 25
$1.8M
$-1.8M
Q2 25
$1.6M
$-1.5M
Q1 25
$1.6M
$-1.5M
Q4 24
$2.1M
$-756.0K
Q3 24
$2.3M
$1.7M
Q2 24
$1.7M
$343.0K
Q1 24
$1.5M
$-1.7M
毛利率
MPTI
MPTI
RMTI
RMTI
Q4 25
21.1%
Q3 25
14.3%
Q2 25
15.6%
Q1 25
16.1%
Q4 24
14.7%
Q3 24
22.0%
Q2 24
17.6%
Q1 24
13.5%
营业利润率
MPTI
MPTI
RMTI
RMTI
Q4 25
27.3%
-2.2%
Q3 25
18.0%
-9.9%
Q2 25
13.9%
-8.4%
Q1 25
15.8%
-7.2%
Q4 24
20.1%
-2.1%
Q3 24
22.1%
6.8%
Q2 24
17.8%
2.0%
Q1 24
16.0%
-5.8%
净利率
MPTI
MPTI
RMTI
RMTI
Q4 25
24.1%
-3.0%
Q3 25
12.9%
-11.0%
Q2 25
11.7%
-9.3%
Q1 25
12.8%
-8.0%
Q4 24
16.7%
-3.1%
Q3 24
17.2%
5.9%
Q2 24
14.8%
1.3%
Q1 24
13.3%
-7.6%
每股收益(稀释后)
MPTI
MPTI
RMTI
RMTI
Q4 25
$0.90
$-0.01
Q3 25
$0.63
$-0.05
Q2 25
$0.53
$-0.05
Q1 25
$0.56
$-0.04
Q4 24
$0.68
$-0.02
Q3 24
$0.81
$0.04
Q2 24
$0.63
$0.01
Q1 24
$0.53
$-0.06

资产负债表与财务实力

最新季度各公司的流动性、杠杆与账面价值一览

指标
MPTI
MPTI
RMTI
RMTI
现金及短期投资手头流动性
$20.9M
$10.7M
总债务越低越好
股东权益账面价值
$63.2M
$37.0M
总资产
$68.4M
$57.1M
负债/权益比越低杠杆越低

8季度趋势,按日历期对齐

现金及短期投资
MPTI
MPTI
RMTI
RMTI
Q4 25
$20.9M
$10.7M
Q3 25
$18.3M
$13.6M
Q2 25
$15.5M
$12.5M
Q1 25
$13.7M
$11.4M
Q4 24
$12.6M
$15.7M
Q3 24
$8.5M
$12.3M
Q2 24
$6.5M
$11.9M
Q1 24
$5.4M
$6.6M
股东权益
MPTI
MPTI
RMTI
RMTI
Q4 25
$63.2M
$37.0M
Q3 25
$37.0M
$37.0M
Q2 25
$34.8M
$30.4M
Q1 25
$33.2M
$31.5M
Q4 24
$31.3M
$32.6M
Q3 24
$26.2M
$29.1M
Q2 24
$23.7M
$23.5M
Q1 24
$21.7M
$20.6M
总资产
MPTI
MPTI
RMTI
RMTI
Q4 25
$68.4M
$57.1M
Q3 25
$42.2M
$57.5M
Q2 25
$39.7M
$52.6M
Q1 25
$37.8M
$54.0M
Q4 24
$36.6M
$59.2M
Q3 24
$31.5M
$57.1M
Q2 24
$28.4M
$53.0M
Q1 24
$26.8M
$50.7M

现金流与资本效率

扣除再投资后实际产生的现金。现金流比净利润更难造假

指标
MPTI
MPTI
RMTI
RMTI
经营现金流最新季度
$2.7M
$2.3M
自由现金流经营现金流 - 资本支出
$2.3M
$2.2M
自由现金流率自由现金流/营收
16.4%
12.0%
资本支出强度资本支出/营收
2.4%
0.5%
现金转化率经营现金流/净利润
0.78×
过去12个月自由现金流最近4个季度
$8.1M
$-1.2M

8季度趋势,按日历期对齐

经营现金流
MPTI
MPTI
RMTI
RMTI
Q4 25
$2.7M
$2.3M
Q3 25
$3.5M
$-1.3M
Q2 25
$2.9M
$1.8M
Q1 25
$1.6M
$-3.5M
Q4 24
$1.8M
$865.0K
Q3 24
$2.3M
$4.3M
Q2 24
$2.0M
$1.4M
Q1 24
$1.5M
$-2.4M
自由现金流
MPTI
MPTI
RMTI
RMTI
Q4 25
$2.3M
$2.2M
Q3 25
$2.7M
$-1.5M
Q2 25
$2.0M
$1.7M
Q1 25
$1.0M
$-3.5M
Q4 24
$1.4M
$470.0K
Q3 24
$1.8M
$4.1M
Q2 24
$1.1M
$1.2M
Q1 24
$1.4M
$-2.5M
自由现金流率
MPTI
MPTI
RMTI
RMTI
Q4 25
16.4%
12.0%
Q3 25
19.1%
-9.6%
Q2 25
15.4%
10.5%
Q1 25
8.0%
-18.8%
Q4 24
10.8%
1.9%
Q3 24
13.4%
14.4%
Q2 24
9.2%
4.5%
Q1 24
12.3%
-11.1%
资本支出强度
MPTI
MPTI
RMTI
RMTI
Q4 25
2.4%
0.5%
Q3 25
5.7%
1.4%
Q2 25
6.1%
1.0%
Q1 25
4.6%
0.3%
Q4 24
3.3%
1.6%
Q3 24
3.6%
0.7%
Q2 24
7.4%
1.1%
Q1 24
1.1%
0.6%
现金转化率
MPTI
MPTI
RMTI
RMTI
Q4 25
0.78×
Q3 25
1.92×
Q2 25
1.83×
Q1 25
0.99×
Q4 24
0.85×
Q3 24
0.99×
2.57×
Q2 24
1.12×
4.20×
Q1 24
1.01×

财务流量对比

营收 → 毛利润 → 营业利润 → 净利润流向图

业务分部营收拆解

MPTI
MPTI

US$11.3M79%
Non Us$2.9M21%

RMTI
RMTI

US$15.9M87%
Non Us$2.4M13%

相关对比